This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 2445
Title
Mucus Viscosity, Increased leads to CBF, Decreased
Upstream event
Downstream event
Key Event Relationship Overview
AOPs Referencing Relationship
Taxonomic Applicability
| Term | Scientific Term | Evidence | Link |
|---|---|---|---|
| Homo sapiens | Homo sapiens | NCBI |
Sex Applicability
| Sex | Evidence |
|---|---|
| Mixed |
Life Stage Applicability
| Term | Evidence |
|---|---|
| All life stages |
Key Event Relationship Description
Under physiological conditions, the viscosity of mucus has been shown to range from 1 to 100 Pa.s under low shear rate conditions and from 0.01 to 1 Pa.s under high shear rate conditions. Mucus viscoelastic properties, whether altered by airway dehydration or mucus hypersecretion, directly influence MCC. Toxicant exposures, such as to nicotine, as well as inflammation can also affect the physicochemical properties of mucus (Chen et al., 2014). Increased mucus viscosity in turn decreases CBF and slows transport of mucus on the mucociliary escalator.
Evidence Collection Strategy
Evidence Supporting this KER
Several studies have shown that there is an optimal range of viscoelastic mucus properties that facilitates efficient MCC and that changes in mucus viscosity beyond that optimal range impact CBF and alter MCC. Studies in humans, mice, hamsters, horses and frogs have shown that increased mucus viscosity correlates with a decrease in CBF (King, 1979; Gheber et al., 1998; Matsui et al., 1998; Andrade et al., 2005; González et al., 2016; Kikuchi et al., 2017; Birket et al., 2018).
Biological Plausibility
Mucus viscoelastic properties, whether altered by airway dehydration or mucus hypersecretion, directly influence MCC. In fact, there is an inverse relationship between mucus viscosity and CBF and mucus transport/MCC, as demonstrated in several in vivo and ex vivo studies. A large proportion of these studies have employed (bio)polymers or other large organic molecules to mimic the mucus layer in the airways and the increase in its viscosity. In addition, some of these studies have shown that decreased mucus viscosity may also result in impairment of MCC. Therefore, a causal link is only tentatively supported. Because cilia function, ASL height, and mucus properties are intricately linked to each other as evidenced by cystic fibrosis studies, we consider the plausibility as moderate.
Empirical Evidence
Exposure of primary cultures of hamster oviductal ciliated cells to increased viscous loading reduced the CBF (Andrade et al., 2005).
The tracheal samples from mice were used to measure ciliary beat frequencies and beat amplitudes of ciliary motion in viscous culture media over the range of η= 0.9–303.8 mPa.s. The CBF decreased with increasing viscosity, up to about 32.0 mPa.s, while it was nearly constant above 32.0 mPa.s (Kikuchi et al., 2017). In tracheal samples from mice, CBF decreased with increasing viscosity, up to about 32.0 mPa.s, while it was nearly constant above 32.0 mPa.s. CBF were calculated from the averaged cycles of beat velocity, with 14.8 ± 3.0 Hz and 9.0 ± 2.4 Hz at η = 0.9 (0% methylcellulose solution) and 32.0 mPa.s (0.3% methylcellulose solution), respectively (Kikuchi et al., 2017).
When the viscosity of medium 199 was increased from 7.8 to 58 mP by adding polyvinylpyrrolidone, CBF of bronchial epithelial cell explants was decreased by ca. 10% from the control value. Medium viscosity of 87 millipoises decreased CBF to 25% from the control value (Luk and Dulfano, 1983).
Treatment of primary bronchial epithelial cell monolayer cultures from G551D/F508del cystic fibrosis patients with 10 µM ivacaftor, a CFTR potentiator, at concentrations ≥ 100 nM for 24 hr and 10 µM forskolin decreased mucus viscosity from 2600 cP to 600 cP at the physiological frequency of 0.9 Hz and increased CBF from ca. 3 Hz to ca. 5 Hz (Birket et al., 2016).
Epithelial cell monolayers from explants of pediatric adenoid tissues were used to assess the impact of viscosity on CBF. A decrease in CBF was observed immediately after the viscosity of the medium was increased, with a greater decrease in CBF in cultures exposed to 20% dextran (González et al., 2016).
Uncertainties and Inconsistencies
Studies interrogating the link between CBF and/or mucus viscosity and MCC found the optimal range of viscoelastic mucus properties to be between 10 and 30 cP and 11 to 25 dyn/cm2 (Chen and Dulfano, 1978; King, 1979; King, 2006; King et al., 1997). These studies also documented that both increases and decreases in mucus viscosity beyond that optimal range impact CBF and decrease and increases, respectively, MCC. A large proportion of these studies utilize (bio)polymers or other large organic molecules to mimic the mucus layer in the airways and increases in its viscosity. Therefore, there may be limitations to the translatability of these findings.
There is at least one study showing that increased mucus viscosity not only slows CBF, but also alters cilia beat metachrony, with medium viscosities in the range of 30–1500 cP increasing metachronal wave velocities by up to 50% and changes in wave direction in cultured frog esophagus (Gheber et al., 1998; Stafanger et al., 1987). CBF also appears to be, at least in part, autoregulated by ciliated respiratory cells, which adjust cilia beating to differences in viscous load via a mechanosensory mechanism (Johnson et al., 1991).
Known modulating factors
Unknown
Quantitative Understanding of the Linkage
The bulk of quantitative data supports the inverse relationship between mucus viscosity and MCC, either via slowing of cilia beating or decreased mucus transport speed. In particular, studies mimicking changes in mucus viscosity by using (bio)polymers or large molecules such as dextran provide insights into the dose-response effects of increasing mucus viscosity on mucociliary transport rates. They do, however, suggest that the effects are transient in nature, at least in ex vivo and in vitro systems. These studies also indicate that there is an optimal range of viscoelastic mucus properties that facilitates efficient MCC and that changes in mucus viscosity beyond that optimal range impact CBF and alter MCC. Because MCC can both decrease and increase dependent on mucus viscosity and because not all studies provide evidence of a causal relationship between these two KEs, we judge our quantitative understanding moderate.
Response-response Relationship
Exposure of primary cultures of hamster oviductal ciliated cells to increased viscous loading reduced the CBF (Andrade et al., 2005).
The tracheal samples from mice were used to measure ciliary beat frequencies and beat amplitudes of ciliary motion in viscous culture media over the range of η= 0.9–303.8 mPa.s. The CBF decreased with increasing viscosity, up to about 32.0 mPa.s, while it was nearly constant above 32.0 mPa.s (Kikuchi et al., 2017).
When the viscosity of medium 199 was increased from 7.8 to 58 millipoises (by adding polyvinylpyrrolidone), CBF of bronchial epithelial cell explants was decreased by ca. 10% from the control value. Medium viscosity of 87 millipoises decreased CBF to 25% from the control value (Luk and Dulfano, 1983).
Treatment of primary bronchial epithelial cell monolayer cultures from G551D/F508del cystic fibrosis patients with 10 µM ivacaftor, a CFTR potentiator, at concentrations ≥ 100 nM for 24 hr and 10 µM forskolin decreased mucus viscosity (from 2600 cP to 600 cP) at the physiological frequency of 0.9 Hz and increased CBF (from ca. 3 Hz to ca. 5 Hz) (Birket et al., 2016).
Epithelial cell monolayers from explants of pediatric adenoid tissues were used to assess the impact of viscosity on CBF. A decrease in CBF was observed immediately after the viscosity of the medium was increased, with a greater decrease in CBF in cultures exposed to 20% dextran (González et al., 2016).
Time-scale
Within the first 10 min, the CBF of human oviductal cells dropped ~35% within the range of 2–37 cP (2–15% dextran solutions), but no further decrease was observed at higher viscosities in the range of 37–200 cP (15–30% dextran solutions) (Andrade et al., 2005).
The CBF decreased with increasing viscosity, up to about 32.0 mPa.s, while it was nearly constant above 32.0 mPa.s. The beat frequencies were calculated from the averaged cycles of beat velocity, 14.8 ± 3.0 Hz and 9.0 ± 2.4 Hz (0% methylcellulose solution) and 32.0 mPa.s (0.3% methylcellulose solution), respectively (Kikuchi et al., 2017).
In epithelial cell monolayers from explants of pediatric adenoid tissues , a decrease in CBF was observed immediately after the viscosity of the medium was increased, with a greater decrease in CBF in cultures exposed to 20% dextran. When cultures, prior to viscosity change, were treated with TNFa, CBF decreased furthermore only in culture exposed to 10% dextran. This effect of TNFa occurs in the first 10 min of viscous load, then TNFa-treated cells seem to adjust the CBF to control values (González et al., 2016).
Known Feedforward/Feedback loops influencing this KER
Unknown
Domain of Applicability
References
- Andrade, Y.N., Fernandes, J., Vázquez, E., Fernández-Fernández, J.M., Arniges, M., Sánchez, T.M., et al. (2005). TRPV4 channel is involved in the coupling of fluid viscosity changes to epithelial ciliary activity. J. Cell Biol. 168(6), 869-874.
- Birket, S.E., Chu, K.K., Houser, G.H., Liu, L., Fernandez, C.M., Solomon, G.M., et al. (2016). Combination therapy with cystic fibrosis transmembrane conductance regulator modulators augment the airway functional microanatomy. Am. J. Physiol. Lung Cell. Mol. Physiol. 310(10), L928-L939.
- Birket, S.E., Davis, J.M., Fernandez, C.M., Tuggle, K.L., Oden, A.M., Chu, K.K., et al. (2018). Development of an airway mucus defect in the cystic fibrosis rat. JCI Insight 3(1), e97199.
- Chen, E.Y., Sun, A., Chen, C.-S., Mintz, A.J., and Chin, W.-C. (2014). Nicotine alters mucin rheological properties. American Journal of Physiology-Lung Cellular and Molecular Physiology 307(2), L149-L157.
- Chen, T., and Dulfano, M. (1978). Mucus viscoelasticity and mucociliary transport rate. The Journal of laboratory and clinical medicine 91(3), 423-431.
- Gheber, L., Korngreen, A., and Priel, Z. (1998). Effect of viscosity on metachrony in mucus propelling cilia. Cell motility and the cytoskeleton 39(1), 9-20.
- González, C., Droguett, K., Rios, M., Cohen, N.A., and Villalón, M. (2016). TNFα Affects Ciliary Beat Response to Increased Viscosity in Human Pediatric Airway Epithelium. Biomed. Res. Int. 2016, 3628501.
- Johnson, N.T., Villalón, M., Royce, F.H., Hard, R., and Verdugo, P. (1991). Autoregulation of beat frequency in respiratory ciliated cells. The American review of respiratory disease 144, 1091-1094.
- Kikuchi, K., Haga, T., Numayama-Tsuruta, K., Ueno, H., and Ishikawa, T. (2017). Effect of fluid viscosity on the cilia-generated flow on a mouse tracheal lumen. Ann. Biomed. Eng. 45(4), 1048-1057.
- King, M. (1979). Interrelation between mechanical properties of mucus and mucociliary transport: effect of pharmacologic interventions. Biorheology 16(1-2), 57-68.
- King, M. (2006). Physiology of mucus clearance. Paediatr. Respir. Rev. 7 Suppl 1, S212-214. doi: 10.1016/j.prrv.2006.04.199.
- King, M., Dasgupta, B., Tomkiewicz, R.P., and Brown, N.E. (1997). Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I. American journal of respiratory and critical care medicine 156(1), 173-177.
- Luk, C.K., and Dulfano, M.J. (1983). Effect of pH, viscosity and ionic-strength changes on ciliary beating frequency of human bronchial explants. Clin Sci (Lond) 64(4), 449-451.
- Matsui, H., Grubb, B.R., Tarran, R., Randell, S.H., Gatzy, J.T., Davis, C.W., et al. (1998). Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95(7), 1005-1015.
- Stafanger, G., Bisgaard, H., Pedersen, M., Mørkassel, E., and Koch, C. (1987). Effect of N-acetylcysteine on the human nasal ciliary activity in vitro. European journal of respiratory diseases 70(3), 157-162.